Sovereign AI Fund invests in Olix
Funding Provisional 95% confidence first seen
Sovereign AI Fund, the UK government's investment vehicle, participated in Olix's $312 million Series B funding round, which valued the London-based AI chip startup at $3.3 billion. The fund joined other investors including Arm, Netflix co-founder Reed Hastings, and Hudson River Trading in backing the company's development of AI inference chips.
The deal
Olix $312M Series B · announced 3 Aug 2026
Investors UK government Sovereign AI fund UK government's Sovereign AI fund Fundemo Sovereign AI Fund UK Sovereign AI fund Arm Reed Hastings
Deal terms as reported in the coverage below.
Decision brief
- What changed
- Olix, a London-based AI chip startup, raised a $312 million Series B round at a $3.3 billion valuation, up from $1 billion just six months earlier, with participation from the UK government's Sovereign AI Fund alongside Arm, Reed Hastings, and Hudson River Trading.
- Why it matters
- This signals UK government willingness to co-invest directly in domestic AI hardware infrastructure, potentially easing capital access and providing a policy tailwind for chip startups targeting inference workloads rather than training. For enterprises, Olix's DX-1 chip claims (10,000+ tokens/sec per user for 100B parameter models, reduced reliance on scarce HBM) suggest a possible alternative supply path for inference compute if the technology delivers at scale.
- Evidence
- Based on a single source (Trending Topics EU); the valuation, funding amount, and investor list are stated as fact but not corroborated by additional independent reporting in the provided coverage.
- What remains uncertain
- It is unclear whether the DX-1 chip's performance claims have been independently verified or benchmarked against competitors like Nvidia or Groq; the strategic rationale and terms of the Sovereign AI Fund's investment (equity stake, governance rights, expected timeline to product delivery) are not detailed in this coverage.
- Monitor next
- Watch for independent technical benchmarks or reviews of the DX-1 chip and any announcements of customer deployments or production timelines.
Analytical support, not advice — assumptions and open questions stated above.